Galantamine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Galantamine. Educational only — not medical advice.
Labeled uses
Galantamine hydrobromide extended-release capsules are indicated for the treatment of mild to moderate dementia of the Alzheimer's type.
Source: FDA labeling via NIH DailyMed (set d1697161…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.